Advaxis Launches MINE(TM) Collaboration

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. ANT
3. SPY
4. FFAI
5. FFR
6. META
7. FICO
8. CART
9. LLY
10. TSLA

Go back to Advaxis Launches MINE(TM) Collaboration

Advaxis (ADXS) Launches MINE Collaboration with MSK Cancer Center

October 27, 2015 9:04 AM EDT

Advaxis (NASDAQ: ADXS) announced the launch of a research collaboration with Memorial Sloan Kettering Cancer Center (MSK), a premier cancer center committed to patient care and innovative research, to evaluate the immunologic and anti-tumor activity of patient tumor-specific, neoepitope-based immunotherapy.

The goal of the collaboration, titled MINE (My Immunotherapy Neo-Epitopes), is to use Advaxiss Lm Technology to develop neo-epitope immunotherapies based on an individual patients tumor (ADXS-NEO). MINE will first focus on a preclinical study of Advaxiss new construct approach to evaluate the immunologic... More